UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Medical Oncology & Hematology

We have assembled teams of renowned physicians, researchers and educators to find better ways to prevent and treat various forms of cancer and blood-related diseases.

We are committed to providing the best treatment available today as well as discovering and evaluating new therapies for the future. This important work saves lives and forever changes the face of cancer and blood-related diseases.

Learn about the Fred & Pamela Buffett Cancer Center

Interim Chief of the Division of Medical Oncology

Nicole Shonka, MD, is the only fellowship-trained neuro-oncologist in the state and her research focuses on brain cancer. She also specializes in the treatment of sarcomas and is involved in clinical and translational research in gliomas.

More about Dr. Shonka

Nicole Shonka, MD

Interim Chief of the Division of Hematology

Matt Lunning, DO, is active in clinical research, research mentoring, education and patient care with a special focus on CAR T-cell therapy. He is also the UNMC Assistant Vice Chancellor of Clinical Research.

More about Dr. Lunning

Matthew Lunning, DO

Lymphoma Research Group

Julie Vose, MD, leads the Lymphoma Research Group. She is a board-certified hematologist and oncologist whose research interests include novel therapies for Hodgkin disease, non-Hodgkin lymphoma, multiple myeloma and chronic lymphocytic leukemia.

Support Our Research